Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mindalin Komplex 26
- Development stage
- Unknown
- Lead developer
- PharmaSGP
- Administration
- Oral
01
Overview
Mindalin Komplex 26 is a dietary supplement drink developed and marketed by PharmaSGP. Formulated as a powder for oral suspension, it contains a complex of 26 micronutrients, including beta-glucan, choline, vitamins, and minerals, along with BioPerine as a biocatalyst to enhance nutrient absorption. The product is designed to support the cardiovascular system by promoting healthy blood vessels, normal blood pressure, healthy heart function, normal blood formation, and efficient oxygen and energy supply.
- Brand names
- Mindalin Komplex 26
- Other names
- Mindalin
Beyond the preview
Go deeper on Mindalin Komplex 26.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mindalin Komplex 26.